Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Trump declared the opioids crisis a national health emergency in October. Photo: Evan Vucci / AP

President Trump's opioid commission delivered more than 50 specific ideas to help combat the epidemic, involving more than a dozen agencies. But no one's in charge of implementing that overall plan — which means no one's accountable for its progress.

Be smart: Policy-specific "czars" can be a bit of a gimmick. But some experts say there's a strong case for giving one person the authority to spearhead an opioid response that will need to be far-reaching and multifaceted to be successful.

"Basically, it really comes down to what Trump wants to do," Ron Klain, who served as President Obama's "Ebola czar," told me. "If he really wants a high-tempo pace of action, really driving action at a wide array of agencies, then perhaps a WH Coordinator would make sense. If this is a PR stunt, with no real policy or action behind it, than a WH Coordinator adds nothing, and just highlights how lagging it is."

Why now? Looking at the report from Trump's opioid commission as well as the steps outside experts have recommended, it's obvious that this will be a complicated solution with a lot of moving parts.

  • The Centers for Disease Control and Prevention is generally in charge of monitoring epidemics.
  • The Food and Drug Administration is re-examining its regulatory rules with an eye toward broader use of medication-assisted therapy, like methadone. It also regulates the design and marketing of opioids that are already on the market.
  • Some of these products are being prescribed or obtained illegally, and people addicted to opioids frequently turn to illegal drugs like heroin, as well. There are roles here not just for health care agencies, but also law enforcement.
  • And all of that has to be coordinated not just within the federal government, but with the relevant agencies in all 50 states, as well as tribal authorities.

"It seems it would be worthwhile to have a separate individual that's focused exclusively on the tasks that are required to fight the current epidemic," said David Fiellin, a public health professor at Yale who led a task force that came up with Connecticut's strategic plan for the opioid epidemic.

Normally, the lead role would likely fall to the Office of National Drug Control Policy, Fiellin said. But ONDCP doesn't have a Senate-confirmed director. Trump's nominee, Tom Marino, withdrew in the wake of reports about his support for a bill that frustrated efforts to crack down on opioid abuse .

  • Even if ONDCP had a permanent leader in place, though, it also has other responsibilities.
  • "At least initially, it would be worthwhile to have an additional person, such that the ONDCP director could continue to focus on the myriad responsibilities they have, and a separate individual [would be] exclusively focused on opioids," Fiellin said.

How it works: There's only so much money and human capacity to go around. A centralized authority figure could help make sure agencies aren't duplicating each other's work, and set priorities those agencies might not arrive at on their own, but which would contribute more to the broader, inter-agency effort.

"I think those types of positions can often set the agenda, set priorities, help to ensure that thing that are being done are expected to generate maximum response," Fiellin said.

Go deeper

Bryan Walsh, author of Future
3 mins ago - Technology

AI is industrializing

Illustration: Sarah Grillo/Axios

Artificial intelligence is becoming a true industry, with all the pluses and minuses that entails, according to a sweeping new report.

Why it matters: AI is now in nearly every area of business, with the pandemic pushing even more investment in drug design and medicine. But as the technology matures, challenges around ethics and diversity grow.

Updated 1 hour ago - Politics & Policy

National Guard chief: Pentagon's "unusual" Jan. 6 restrictions led to 3-hour delay

William Walker, commanding general of the D.C. National Guard, testified Wednesday that a three-hour delay in approval for National Guard assistance during the Jan. 6 Capitol attack was exacerbated by "unusual" restrictions on his authorities by Pentagon leadership.

Why it matters: Walker testified that if Army Secretary Ryan McCarthy had not prohibited him in a Jan. 5 memo from using the National Guard's "Quick Reaction Force" without authorization, he would have "immediately" sent troops to the Capitol after receiving a "frantic call" from then-Capitol Police Chief Steven Sund.

2 hours ago - World

U.S.-Iran nuclear diplomacy is going nowhere fast

Illustration: Annelise Capossela/Axios

Iran's cool response to the Biden administration's push for diplomatic engagement, along with rising tensions in the region, makes clear that salvaging the 2015 nuclear deal may be far more difficult than many had anticipated.

The state of play: Both the U.S. and Iran have entered the diplomatic dance, but it seems to be moving in circles.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!